RBC Capital sets $70 price target for 10x Genomics
Benzinga reports RBC Capital initiated coverage on 10x Genomics at Sector Perform and set a $70.00/share price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.